Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETRY
NCT00234676Phase 2Completed
- Sponsor
- Parkinson Study Group
- Start
- Oct 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Premarin with Placebo (2 arms). Primary endpoints: Adverse event frequency and vital signs at 60 days and Proportion of participants who complete the trial at 60 days. Started Oct 2003; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00234676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234676.